About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Parkinson's Disease Clinical Trials | 122 Studies Recruiting

Clinical TrialsParkinson's Disease

Parkinson's Disease Clinical Trials

Browse 122 clinical trials for parkinson's disease. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 122 trials

Not yet recruitingVibrotactile Coordinated Reset for Parkinsons Patients Who Are on Dopaminergic MedicationThe purpose of this clinical trial is to test the efficacy of vibrotactile coordinated reset stimulation to improve movement ability and other symptoms of human subject…NCT06583005 RecruitingHome-based Gait and Balance Training in Patients With Movement DisordersThe research project is an experimental study with three study visits at the study site at the University Hospital Düsseldorf (UKD) / Heinrich Heine University Düsseldorf (HHU)…NCT06617884·Düsseldorf, North Rhine-Westphalia CompletedA Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinson's DiseaseThe study objective is to explore Deep Brain Stimulation (DBS) in two specific brain regions (Globus Pallidum, or GPI, plus the pedunculopontine nucleus, or PPN) for on medication…NCT02318927·Gainesville, Florida

Related Searches

parkinsonstrials

Data from ClinicalTrials.govTerms

CompletedOpen Label Single Arm Prebiotic Pilot Trial SR001The goal of this pilot clinical study is to evaluate the effect of a prebiotic fiber blend in individuals diagnosed with Parkinson's Disease.NCT07127120·Northbrook, Illinois

RecruitingDirectional PSA Versus STN DBS for TD-PDThe aim of this study is to compare the effectiveness of the deep brain stimulation in the posterior subthalamic area (PSA) versus the subthalamic nucleus (STN) using directional…NCT07700862·Shanghai

TerminatedQuantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's DiseaseLevodopa is the main drug treatment for Parkinson's disease. Levodopa can cause unwanted and uncontrolled movements called dyskinesias.NCT00794313·Portland, Oregon

RecruitingAt-home taVNS for Neurorehabilitation in Parkinson's DiseaseThe goal of this clinical trial is to learn if taVNS works to treat symptoms of Parkinson's Disease in adults.NCT07536022·Charleston, South Carolina

WithdrawnAttention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy BodiesThe purpose of this study is to evaluate if a drug commonly used to treat excessive day-time sleepiness, called armodafinil (Nuvigil), is also effective in improving the…NCT01256905·New York, New York

WithdrawnA Pilot Study to Explore the Role of Gut Flora in Parkinson's DiseaseThis study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Parkinson's Disease.NCT04148326·Ventura, California

UnknownEffect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)This will be a Phase II single center, double-blind, randomized, placebo-controlled, efficacy study. Subjects will complete six visits.NCT03567447·Phoenix, Arizona

Not yet recruitingVibrotactile Coordinated Reset (vCR) for the Treatment of Advanced Parkinson's Disease Patients Who Have Previously Received vCR StimulationThe purpose of this study is to test the efficacy of vibrotactile coordinated reset(vCR) stimulation on human subject participants with advanced stage Parkinson's Disease who have…NCT06559098

CompletedA Study of NE3107 in Early Parkinson'sThe goal of this clinical trial is to learn if bezisterim can treat movement symptoms of Parkinson's disease in patients that are 45 to 80 years old, in generally good physical…NCT06757010·Farmington Hills, Michigan and 3 others

CompletedReducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty AcidsThe purpose of this research study is to measure the safety (side effects) of an Omega 3 Fatty acid called docosahexanoic acid (DHA) and measure the dyskinesia (involuntary…NCT01563913·Portland, Oregon

CompletedOnline Cognitive Behavioral Therapy for Depressive Symptoms in Parkinson's DiseaseMore than 1 million people in Europe suffer from Parkinson's disease (PD), a brain disorder manifesting with a motor syndrome and several non-motor features.NCT05585827·Stavanger

RecruitingEffects of Microelectrode-based Brain Stimulation in HumansThe currently available treatments of Parkinson's disease (PD) and Essential Tremor (ET) are inadequate and accompanied by adverse side effects making the treatment much less…NCT07820189·Lund, Skåne County

Enrolling by invitationInternet Delivered Cognitive Rehabilitation for Mild Cognitive ImpairmentsAcquired brain injury and neurological disorders cause cognitive deficits, which in turn cause reduced participation in everyday life.NCT06973018·Stockholm, Stockholm County

CompletedKinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of LifeThe study will compare the effect of pramipexole on different types of tremor and particularly kinetic tremor in early and advanced Parkinson's disease patients and will evaluate…NCT01100073·Keila and 214 others

RecruitingNutritional Intervention for Constipation Symptoms in Patients With Parkinson's DiseaseThe goal of this clinical trial is to evaluate whether a dietitian-guided nutritional intervention can improve constipation symptoms in people with Parkinson's disease (PD).NCT07213856·Porto Alegre, Rio Grande do Sul

CompletedManaging Fatigue in People With Parkinson's DiseaseThis pilot study aims to evaluate the feasibility of Managing Fatigue: The Individual Program (MFIP) in people living with Parkinson's disease.NCT04267107·Halifax, NovaScotia

RecruitingA Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor ComplicationsThis registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years.NCT05539196·Baltimore, Maryland and 4 others

PreviousPage 2 of 7Next